<DOC>
	<DOCNO>NCT00002235</DOCNO>
	<brief_summary>Indinavir usually take three time day . The purpose study see safe effective take indinavir twice day plus nelfinavir ( also take twice day ) efavirenz ( take day ) .</brief_summary>
	<brief_title>A Study Safety Effectiveness Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors ( NNRTIs ) Protease Inhibitors</brief_title>
	<detailed_description>Patients receive treatment regimen consist nelfinavir , indinavir , efavirenz 48 week . During study , patient evaluate change baseline plasma HIV-1 RNA level lymphocyte subset development adverse event toxicity . After Week 48 , patient document virologic response eligible continue receive study treatment attend schedule follow-up visit . Patients experience virologic failure discontinue study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are HIVpositive . Are least 13 year old ( consent parent guardian require 18 ) . Have viral load least 10,000 copies/ml within 30 day study entry . Agree use barrier method birth control , condom , study . Exclusion Criteria You eligible study : Have hepatitis . Have serious medical condition besides HIV infection . Are allergic indinavir , nelfinavir , efavirenz . Have ever take NNRTIs protease inhibitor . Have chemotherapy radiation therapy within 30 day study entry . ( Local radiation therapy allow . ) Have take certain medication might affect immune system interleukin2 , interferon , vaccine within 30 day study entry . Are enrol plan enroll another antiHIV drug study study . Are pregnant breastfeeding . Abuse alcohol drug .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2000</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Indinavir</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>efavirenz</keyword>
</DOC>